Elizabeth City, NC, United States of America

Tesfaye Serbessa

This inventor holds 1 USPTO granted patent. Top assignee: Tuskegee University. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Tesfaye Serbessa

Introduction

Tesfaye Serbessa is a notable inventor based in Elizabeth City, North Carolina. He has made significant contributions to the field of cancer treatment through his innovative research and development of anticancer methods. His work focuses on utilizing analogs and derivatives of 3-(2-substituted-ethyl) indole compounds to inhibit cancer cell proliferation.

Latest Patents

Tesfaye Serbessa holds one patent that details methods for inhibiting cancer cell proliferation and killing cancer cells. This patent discloses treatment methods involving indole compounds with a specific structural formula, where R is defined within the patent documentation. His research aims to provide effective solutions for cancer treatment, showcasing his commitment to advancing medical science.

Career Highlights

Serbessa is affiliated with Tuskegee University, where he continues to engage in groundbreaking research. His academic and professional journey reflects a dedication to improving health outcomes through innovative scientific approaches. His work has the potential to impact the lives of many individuals affected by cancer.

Collaborations

Some of his notable coworkers include Temesgen Samuel and Teshome Yehualaeshet. Their collaborative efforts contribute to the advancement of research in cancer treatment and enhance the overall impact of their findings.

Conclusion

Tesfaye Serbessa's contributions to cancer treatment through his innovative patent highlight the importance of research and collaboration in the medical field. His work exemplifies the potential of scientific innovation to address critical health challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…